Therefore, we planned to study the effect of saroglitazar on insulin sensitivity in patients with type 2 diabetes mellitus (T2DM) with hypertriglyceridemia by hyperinsulinemic-euglycemic clamp. Here, INS is linked to type 2 diabetes mellitus.